Notch signaling pathway inhibitor

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Notch signaling pathway inhibitor, covering 2015-01-30 to 2015-01-30. Get the full timeline:

Most recent: Clinical Trial Update: A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014) [Phase 1]